Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021

SELL
$67.69 - $73.03 $1.67 Million - $1.8 Million
-24,715 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$63.47 - $69.35 $168,703 - $184,332
-2,658 Reduced 9.71%
24,715 $1.7 Million
Q1 2021

Apr 29, 2021

SELL
$60.0 - $68.46 $48,780 - $55,657
-813 Reduced 2.88%
27,373 $1.77 Million
Q4 2020

Feb 05, 2021

SELL
$56.65 - $64.55 $16,995 - $19,365
-300 Reduced 1.05%
28,186 $1.64 Million
Q3 2020

Nov 09, 2020

SELL
$62.1 - $78.08 $28,566 - $35,916
-460 Reduced 1.59%
28,486 $1.8 Million
Q2 2020

Aug 05, 2020

SELL
$72.34 - $84.0 $9,910 - $11,508
-137 Reduced 0.47%
28,946 $2.23 Million
Q1 2020

May 11, 2020

BUY
$62.63 - $80.22 $1.82 Million - $2.33 Million
29,083 New
29,083 $2.17 Million
Q2 2019

Aug 06, 2019

SELL
$61.87 - $69.38 $196,127 - $219,934
-3,170 Closed
0 $0
Q1 2019

May 07, 2019

SELL
$62.53 - $70.05 $151,635 - $169,871
-2,425 Reduced 43.34%
3,170 $206,000
Q4 2018

Feb 06, 2019

SELL
$60.54 - $79.0 $59,026 - $77,025
-975 Reduced 14.84%
5,595 $350,000
Q3 2018

Nov 06, 2018

SELL
$71.28 - $78.92 $3,564 - $3,946
-50 Reduced 0.76%
6,570 $507,000
Q2 2018

Aug 08, 2018

SELL
$64.88 - $75.68 $71,368 - $83,248
-1,100 Reduced 14.25%
6,620 $469,000
Q1 2018

May 04, 2018

SELL
$72.84 - $88.8 $25,494 - $31,080
-350 Reduced 4.34%
7,720 $582,000
Q3 2017

Nov 06, 2017

BUY
$72.11 - $85.47 $12,619 - $14,957
175 Added 2.22%
8,070 $654,000
Q2 2017

Aug 08, 2017

BUY
N/A
7,895
7,895 $559,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Private Harbour Investment Management & Counsel, LLC Portfolio

Follow Private Harbour Investment Management & Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Harbour Investment Management & Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Harbour Investment Management & Counsel, LLC with notifications on news.